171 related articles for article (PubMed ID: 3548596)
21. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
[TBL] [Abstract][Full Text] [Related]
22. Poly (γ, L-glutamic acid)-cisplatin bioconjugate exhibits potent antitumor activity with low toxicity: a comparative study with clinically used platinum derivatives.
Feng Z; Lai Y; Ye H; Huang J; Xi XG; Wu Z
Cancer Sci; 2010 Nov; 101(11):2476-82. PubMed ID: 20813014
[TBL] [Abstract][Full Text] [Related]
23. [Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer].
Uchida N; Yamada H; Maekawa R; Yoshioka T
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1943-9. PubMed ID: 12465394
[TBL] [Abstract][Full Text] [Related]
24. Effect of human lymphoblastoid interferon on human yolk sac tumors in nude mice.
Sawada M; Matsui Y; Okudaira Y
Biken J; 1983 Dec; 26(4):169-73. PubMed ID: 6204635
[TBL] [Abstract][Full Text] [Related]
25. [Effects of cis-platinum diammine dichloride on yolk sac tumor transplanted in nude mice (author's transl)].
Sawada M; Matsui Y; Nishiura H; Yagyu M; Hayakawa K; Okudaira Y; Kawashima M; Iwanaga K
Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):519-24. PubMed ID: 7195137
[TBL] [Abstract][Full Text] [Related]
26. [Antitumor effect of JM-8 (a cisplatin analogue) on testicular cancer cells in vitro and in vivo].
Hashimura T; Okada K; Yoshida O
Gan To Kagaku Ryoho; 1985 May; 12(5):1137-42. PubMed ID: 3888118
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.
Kim DK; Kim HT; Cho YB; Tai JH; Ahn JS; Kim TS; Kim KH; Hong WS
Cancer Chemother Pharmacol; 1995; 35(5):441-5. PubMed ID: 7850928
[TBL] [Abstract][Full Text] [Related]
28. [Second-generation cisplatin analogs].
Ariyoshi Y; Ota K
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1043-50. PubMed ID: 3551846
[TBL] [Abstract][Full Text] [Related]
29. Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
Kyriazis AP; Yagoda A; Kyriazis AA; Fogh J
Cancer Res; 1985 May; 45(5):2012-5. PubMed ID: 3886128
[TBL] [Abstract][Full Text] [Related]
30. [Anti-cancer drug sensitivity test against human testicular cancer xenograft--comparison with clinical results of chemotherapy].
Miki T; Kotake T
Hinyokika Kiyo; 1988 Nov; 34(11):1903-9. PubMed ID: 3242364
[TBL] [Abstract][Full Text] [Related]
31. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
Endoh K; Akamatsu K; Matsumoto T; Morikawa K; Honda M; Mitsui H; Koizumi M; Koizumi K; Matsuno T
Anticancer Res; 1989; 9(4):987-91. PubMed ID: 2817826
[TBL] [Abstract][Full Text] [Related]
32. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
[TBL] [Abstract][Full Text] [Related]
33. [Chemotherapy of yolk sac tumor heterotransplanted to nude mice (author's transl)].
Sawada M; Hayakawa K; Matsui Y; Nishiura H; Okudaira Y
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1596-602. PubMed ID: 7240825
[TBL] [Abstract][Full Text] [Related]
34. Response of nude mouse-grown adenocarcinomas of the human exocrine pancreas to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
Kyriazis AP; Kyriazis AA; Yagoda A; Fogh J
Cancer Res; 1985 Sep; 45(9):4354-9. PubMed ID: 3896479
[TBL] [Abstract][Full Text] [Related]
35. Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivo.
McKeage MJ; Kelland LR; Boxall FE; Valenti MR; Jones M; Goddard PM; Gwynne J; Harrap KR
Cancer Res; 1994 Aug; 54(15):4118-22. PubMed ID: 8033145
[TBL] [Abstract][Full Text] [Related]
36. Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
Chang MJ; Yu WD; Reyno LM; Modzelewski RA; Egorin MJ; Erkmen K; Vlock DR; Furmanski P; Johnson CS
Cancer Res; 1994 Oct; 54(20):5380-6. PubMed ID: 7923169
[TBL] [Abstract][Full Text] [Related]
37. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
Rice JR; Gerberich JL; Nowotnik DP; Howell SB
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of new platinum analog DPPE in an orthotopic nude mouse model of human colon cancer.
Rho YS; Lee KT; Jung JC; Yoon C; An Z; Hoffman RM; Chang SG
Anticancer Res; 1999; 19(1A):157-61. PubMed ID: 10226537
[TBL] [Abstract][Full Text] [Related]
39. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).
Curt GA; Grygiel JJ; Corden BJ; Ozols RF; Weiss RB; Tell DT; Myers CE; Collins JM
Cancer Res; 1983 Sep; 43(9):4470-3. PubMed ID: 6347373
[TBL] [Abstract][Full Text] [Related]
40. [Antitumor effects of human interferon on human tumors heterotransplanted into nude mice].
Sawada M; Oshikane M; Matsui Y; Okudaira Y; Kawashima M; Iwanaga K
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1559-65. PubMed ID: 6182258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
